PL3768248T3 - Stała tabletka farmaceutyczna - Google Patents
Stała tabletka farmaceutycznaInfo
- Publication number
- PL3768248T3 PL3768248T3 PL19714544.4T PL19714544T PL3768248T3 PL 3768248 T3 PL3768248 T3 PL 3768248T3 PL 19714544 T PL19714544 T PL 19714544T PL 3768248 T3 PL3768248 T3 PL 3768248T3
- Authority
- PL
- Poland
- Prior art keywords
- solid pharmaceutical
- pharmaceutical tablet
- tablet
- solid
- pharmaceutical
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
- A61K33/10—Carbonates; Bicarbonates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
- A61K9/0058—Chewing gums
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
- A61K31/167—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2009—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/2031—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyethylene oxide, poloxamers
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Inorganic Chemistry (AREA)
- Nutrition Science (AREA)
- Physiology (AREA)
- Zoology (AREA)
- Pain & Pain Management (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US15/933,942 US10980831B2 (en) | 2018-03-23 | 2018-03-23 | Solid pharmaceutical tablet |
| PCT/DK2019/050100 WO2019179589A1 (en) | 2018-03-23 | 2019-03-21 | A solid pharmaceutical tablet |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL3768248T3 true PL3768248T3 (pl) | 2023-08-28 |
Family
ID=65995450
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL19714544.4T PL3768248T3 (pl) | 2018-03-23 | 2019-03-21 | Stała tabletka farmaceutyczna |
Country Status (10)
| Country | Link |
|---|---|
| US (3) | US10980831B2 (pl) |
| EP (2) | EP3831368A1 (pl) |
| JP (1) | JP7303211B2 (pl) |
| CN (1) | CN111902135A (pl) |
| AU (2) | AU2019239514B2 (pl) |
| BR (1) | BR112020018025A2 (pl) |
| CA (1) | CA3094737A1 (pl) |
| ES (1) | ES2951267T3 (pl) |
| PL (1) | PL3768248T3 (pl) |
| WO (1) | WO2019179589A1 (pl) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2025230986A1 (en) * | 2024-04-29 | 2025-11-06 | Anju Majeed | Aqueous dispersion of molecules-process, formulation and method thereof |
Family Cites Families (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4327076A (en) * | 1980-11-17 | 1982-04-27 | Life Savers, Inc. | Compressed chewable antacid tablet and method for forming same |
| US4753805A (en) | 1984-01-31 | 1988-06-28 | Warner-Lambert Company | Tabletted chewing gum composition and method of preparation |
| ZA87994B (en) | 1986-02-27 | 1987-09-30 | Warner Lambert Co | Antacid chewing gum |
| JPH0695888B2 (ja) | 1989-10-18 | 1994-11-30 | 株式会社サンギ | カルシウム補給用チューインガム |
| US5637313A (en) | 1994-12-16 | 1997-06-10 | Watson Laboratories, Inc. | Chewable dosage forms |
| RU2226060C2 (ru) | 1999-04-15 | 2004-03-27 | Вм.Ригли Дж.Компани | Не содержащая сахара жевательная резинка для реминерализации зубной эмали (варианты) и способ реминерализации зубов |
| US7244455B2 (en) | 2002-01-16 | 2007-07-17 | Warner-Lambert Company | Center-filled chewing gum containing a deliverable form of calcium |
| EP1495680A1 (en) | 2003-07-08 | 2005-01-12 | Gum Base Co. S.p.A. | Gum base for chewing gum |
| CA2578595C (en) * | 2004-06-29 | 2013-02-19 | Fertin Pharma A/S | Tobacco alkaloid releasing chewing gum |
| ATE418328T1 (de) | 2004-07-06 | 2009-01-15 | Gumlink As | Komprimierte kaugummitablette |
| US8765178B2 (en) | 2006-07-19 | 2014-07-01 | Watson Laboratories, Inc. | Controlled release formulations and associated methods |
| AU2008220845B2 (en) | 2007-02-26 | 2013-10-03 | Revolymer Limited | Medicated chewing gum |
| WO2015070875A1 (en) | 2013-11-15 | 2015-05-21 | Fertin Pharma A/S | Chewing gum suitable for diabetics |
| JP6682450B2 (ja) | 2014-04-08 | 2020-04-15 | フェルティン ファルマ アー/エス | 医療用チューインガム |
| GB2542192A (en) * | 2015-09-11 | 2017-03-15 | Revolymer (Uk) Ltd | Chewable medicament |
| WO2017059858A1 (en) | 2015-10-07 | 2017-04-13 | Fertin Pharma A/S | Chewing gum comprising nicotine |
| ITUA20163230A1 (it) | 2016-05-06 | 2017-11-06 | Perfetti Van Melle Spa | Gomma da masticare con stevia |
| US10933017B2 (en) | 2019-03-01 | 2021-03-02 | Nordiccan A/S | Tableted cannabinoid chewing gum with polyvinyl acetate elastomer plasticizers |
-
2018
- 2018-03-23 US US15/933,942 patent/US10980831B2/en active Active
-
2019
- 2019-03-21 US US17/040,444 patent/US11730757B2/en active Active
- 2019-03-21 JP JP2020550793A patent/JP7303211B2/ja active Active
- 2019-03-21 BR BR112020018025-4A patent/BR112020018025A2/pt unknown
- 2019-03-21 PL PL19714544.4T patent/PL3768248T3/pl unknown
- 2019-03-21 CA CA3094737A patent/CA3094737A1/en active Pending
- 2019-03-21 WO PCT/DK2019/050100 patent/WO2019179589A1/en not_active Ceased
- 2019-03-21 CN CN201980021188.9A patent/CN111902135A/zh active Pending
- 2019-03-21 AU AU2019239514A patent/AU2019239514B2/en active Active
- 2019-03-21 EP EP20216277.2A patent/EP3831368A1/en active Pending
- 2019-03-21 EP EP19714544.4A patent/EP3768248B1/en active Active
- 2019-03-21 ES ES19714544T patent/ES2951267T3/es active Active
-
2021
- 2021-03-19 US US17/206,226 patent/US11723918B2/en active Active
-
2024
- 2024-05-01 AU AU2024202892A patent/AU2024202892B2/en active Active
Also Published As
| Publication number | Publication date |
|---|---|
| EP3768248B1 (en) | 2023-06-14 |
| US20210205355A1 (en) | 2021-07-08 |
| EP3768248C0 (en) | 2023-06-14 |
| US11730757B2 (en) | 2023-08-22 |
| JP2021518412A (ja) | 2021-08-02 |
| US20210023128A1 (en) | 2021-01-28 |
| JP7303211B2 (ja) | 2023-07-04 |
| EP3831368A1 (en) | 2021-06-09 |
| EP3768248A1 (en) | 2021-01-27 |
| WO2019179589A1 (en) | 2019-09-26 |
| US11723918B2 (en) | 2023-08-15 |
| AU2019239514B2 (en) | 2024-02-01 |
| US20190290684A1 (en) | 2019-09-26 |
| CN111902135A (zh) | 2020-11-06 |
| BR112020018025A2 (pt) | 2020-12-22 |
| CA3094737A1 (en) | 2019-09-26 |
| US10980831B2 (en) | 2021-04-20 |
| ES2951267T3 (es) | 2023-10-19 |
| AU2019239514A1 (en) | 2020-10-29 |
| AU2024202892A1 (en) | 2024-05-23 |
| AU2024202892B2 (en) | 2025-01-16 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| GB2572126B (en) | Pharmaceutical | |
| GB2569961B (en) | Pharmaceutical | |
| GB2572125B (en) | Pharmaceutical | |
| SI3529248T1 (sl) | Farmacevtske spojine | |
| DK3655017T3 (da) | Farmaceutisk sammensætning | |
| EP3689892A4 (en) | RADIOACTIVE MEDICINAL PRODUCT | |
| EP3603642A4 (en) | PHARMACEUTICAL PREPARATION | |
| DK3529240T3 (da) | Farmaceutiske forbindelser | |
| DK3634377T3 (da) | Farmaceutisk formulering | |
| IL283900A (en) | Pharmaceutical combinations | |
| EP3756639C0 (en) | TABLET CASSETTE | |
| EP3449912A4 (en) | MELTING TABLET | |
| DK3583943T3 (da) | Farmaceutisk sammensætning | |
| EP3486117A4 (en) | TABLE UNIT | |
| EP3646866A4 (en) | PHARMACEUTICAL PREPARATION | |
| EP3881897A4 (en) | LAXATIVE IN TABLET FORM | |
| DK3728220T3 (da) | Farmaceutiske forbindelser | |
| PL3694522T3 (pl) | Dwuwarstwowa formulacja tabletki farmaceutycznej | |
| HUE069648T2 (hu) | Gyógyszerészeti készítmény | |
| DK3432887T3 (da) | Anti-tuberkulosemiddel | |
| EP3727485C0 (en) | PHARMACEUTICAL COMPOSITION | |
| EP3646865A4 (en) | MEDICINE | |
| EP3590513A4 (en) | DRUG | |
| DK3601277T3 (da) | Farmaceutisk formulering | |
| PL3965739T3 (pl) | Postacie dawkowane będące tabletkami oleilofosfocholiny |